Bank Of Montreal

ProShares Ultra Bloomberg Natural Gas

Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily Small Cap Bull 3X ETF

Direxion Daily Semicondct Bull 3X ETF

VS TR -1x Short VIX Futures ETF

Direxion Daily Financial Bull 3X ETF

ARK Innovation ETF

United States Natural Gas

ProShares UltraPro Dow30

VS TR 2x Long VIX Futures ETF

ProShares Ultra VIX Short-Term Futures

ProShares UltraShort Bloomberg Natrl Gas

Direxion Daily S&P Biotech Bear 3X ETF

Direxion Daily Small Cap Bear 3X ETF

Direxion Daily Semicondct Bear 3X ETF

Direxion Financial Bear 3X Shar

Direxion Daily 20+ Yr Trsy Bear 3X ETF

Direxion Technology Bear 3X Shares

Genworth Financial Inc Common Stock

Granite Point Mortgage Trust Inc. Common Stock

JinkoSolar Holding Company Limited American Depositary Shares (each representing 4 Common Shares)

RE/MAX Holdings Inc. Class A Common Stock

TKO Group Holdings Inc. Class A Common Stock

WESCO International Inc. Common Stock

QuantumScape Corporation Class A Common Stock

Reddit Inc. Class A Common Stock

Carvana Co. Class A Common Stock

ChargePoint Holdings Inc. Common Stock

Allstate Corporation (The) Common Stock

Halliburton Company Common Stock

UBS Group AG Registered Ordinary Shares

Hecla Mining Company Common Stock

CVR Energy Inc. Common Stock

Telefonica SA Common Stock

Spotify Technology S.A. Ordinary Shares

Valero Energy Corporation Common Stock

ServiceNow Inc. Common Stock

Grupo Aeroportuario del Sureste S.A. de C.V. Common Stock

Click here to get full coverage on Adaptive Biotechnologies (ADPT) Initiates Coverage with Buy Rating | ADPT Stock News - GuruFocus

Adaptive Biotechnologies (ADPT) Initiates Coverage with Buy Rating | ADPT Stock News  GuruFocus

Adaptive Biotechnologies (ADPT) Initiates Coverage with Buy Rating | ADPT Stock News - GuruFocus

Click here to get full coverage on Assessing Adaptive Biotechnologies: Insights From 5 Financial Analysts - Benzinga

Assessing Adaptive Biotechnologies: Insights From 5 Financial Analysts  Benzinga

Assessing Adaptive Biotechnologies: Insights From 5 Financial Analysts - Benzinga

Click here to get full coverage on What Makes Adaptive Biotechnologies (ADPT) a New Buy Stock - Nasdaq

What Makes Adaptive Biotechnologies (ADPT) a New Buy Stock  Nasdaq

What Makes Adaptive Biotechnologies (ADPT) a New Buy Stock - Nasdaq

Click here to get full coverage on Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?  Yahoo Finance

Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Click here to get full coverage on Adaptive Biotechnologies (ADPT) Sees Positive Growth Prospects | - GuruFocus

Adaptive Biotechnologies (ADPT) Sees Positive Growth Prospects |  GuruFocus

Adaptive Biotechnologies (ADPT) Sees Positive Growth Prospects | - GuruFocus

Click here to get full coverage on Market Participants Recognise Adaptive Biotechnologies Corporation's (NASDAQ:ADPT) Revenues Pushing Shares 29% Higher - simplywall.st

Market Participants Recognise Adaptive Biotechnologies Corporation's (NASDAQ:ADPT) Revenues Pushing Shares 29% Higher  simplywall.st

Market Participants Recognise Adaptive Biotechnologies Corporation's (NASDAQ:ADPT) Revenues Pushing Shares 29% Higher - simplywall.st

Click here to get full coverage on Craig-Hallum Initiates Adaptive Biotechnologies at Buy With $15 Price Target - marketscreener.com

Craig-Hallum Initiates Adaptive Biotechnologies at Buy With $15 Price Target  marketscreener.com

Craig-Hallum Initiates Adaptive Biotechnologies at Buy With $15 Price Target - marketscreener.com

Click here to get full coverage on Save the Date: Adaptive Biotechnologies Q1 Earnings Call - Key Details Inside - Stock Titan

Save the Date: Adaptive Biotechnologies Q1 Earnings Call - Key Details Inside  Stock Titan

Save the Date: Adaptive Biotechnologies Q1 Earnings Call - Key Details Inside - Stock Titan

Click here to get full coverage on Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results  GlobeNewswire

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire

Click here to get full coverage on Adaptive Biotechnologies (ADPT) Receives New Buy Rating and Pric - GuruFocus

Adaptive Biotechnologies (ADPT) Receives New Buy Rating and Pric  GuruFocus

Adaptive Biotechnologies (ADPT) Receives New Buy Rating and Pric - GuruFocus

Click here to get full coverage on Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year?  Yahoo Finance

Is Adaptive Biotechnologies (ADPT) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Click here to get full coverage on $ADPT stock is up 2% today. Here's what we see in our data. - Nasdaq

$ADPT stock is up 2% today. Here's what we see in our data.  Nasdaq

$ADPT stock is up 2% today. Here's what we see in our data. - Nasdaq

Click here to get full coverage on Adaptive Biotechnologies (ADPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Nasdaq

Adaptive Biotechnologies (ADPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates  Nasdaq

Adaptive Biotechnologies (ADPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Nasdaq

Click here to get full coverage on Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.57 - Yahoo Finance

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.57  Yahoo Finance

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.57 - Yahoo Finance

Click here to get full coverage on Adaptive Biotechnologies Corp (ADPT) Q1 2025 Earnings Call Highlights: Strong MRD Revenue ... - Yahoo Finance

Adaptive Biotechnologies Corp (ADPT) Q1 2025 Earnings Call Highlights: Strong MRD Revenue ...  Yahoo Finance

Adaptive Biotechnologies Corp (ADPT) Q1 2025 Earnings Call Highlights: Strong MRD Revenue ... - Yahoo Finance

Click here to get full coverage on Insider Sale: Director at $ADPT Sells 36,291 Shares - Nasdaq

Insider Sale: Director at $ADPT Sells 36,291 Shares  Nasdaq

Insider Sale: Director at $ADPT Sells 36,291 Shares - Nasdaq

Click here to get full coverage on $ADPT stock is up 8% today. Here's what we see in our data. - Nasdaq

$ADPT stock is up 8% today. Here's what we see in our data.  Nasdaq

$ADPT stock is up 8% today. Here's what we see in our data. - Nasdaq

Click here to get full coverage on Does Adaptive Biotechnologies (ADPT) Have the Potential to Rally 26.45% as Wall Street Analysts Expect? - Yahoo Finance

Does Adaptive Biotechnologies (ADPT) Have the Potential to Rally 26.45% as Wall Street Analysts Expect?  Yahoo Finance

Does Adaptive Biotechnologies (ADPT) Have the Potential to Rally 26.45% as Wall Street Analysts Expect? - Yahoo Finance

Click here to get full coverage on ADAPTIVE BIOTECH Earnings Results: $ADPT Reports Quarterly Earnings - Nasdaq

ADAPTIVE BIOTECH Earnings Results: $ADPT Reports Quarterly Earnings  Nasdaq

ADAPTIVE BIOTECH Earnings Results: $ADPT Reports Quarterly Earnings - Nasdaq

Click here to get full coverage on Even though Adaptive Biotechnologies (NASDAQ:ADPT) has lost US$147m market cap in last 7 days, shareholders are still up 147% over 1 year - simplywall.st

Even though Adaptive Biotechnologies (NASDAQ:ADPT) has lost US$147m market cap in last 7 days, shareholders are still up 147% over 1 year  simplywall.st

Even though Adaptive Biotechnologies (NASDAQ:ADPT) has lost US$147m market cap in last 7 days, shareholders are still up 147% over 1 year - simplywall.st

Click here to get full coverage on Adaptive's clonoSEQ Test Secures Strong $2,007 Medicare Reimbursement Rate for 2025 - Stock Titan

Adaptive's clonoSEQ Test Secures Strong $2,007 Medicare Reimbursement Rate for 2025  Stock Titan

Adaptive's clonoSEQ Test Secures Strong $2,007 Medicare Reimbursement Rate for 2025 - Stock Titan

Click here to get full coverage on Adaptive Biotechnologies (ADPT) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

Adaptive Biotechnologies (ADPT) is a Great Momentum Stock: Should You Buy?  Yahoo Finance

Adaptive Biotechnologies (ADPT) is a Great Momentum Stock: Should You Buy? - Yahoo Finance

Click here to get full coverage on Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Call Highlights: Strong MRD Revenue ... - Yahoo Finance

Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Call Highlights: Strong MRD Revenue ...  Yahoo Finance

Adaptive Biotechnologies Corp (ADPT) Q4 2024 Earnings Call Highlights: Strong MRD Revenue ... - Yahoo Finance

Click here to get full coverage on Adaptive Biotechnologies Corporation 2025 Q1 - Results - Earnings Call Presentation (NASDAQ:ADPT) - Seeking Alpha

Adaptive Biotechnologies Corporation 2025 Q1 - Results - Earnings Call Presentation (NASDAQ:ADPT)  Seeking Alpha

Adaptive Biotechnologies Corporation 2025 Q1 - Results - Earnings Call Presentation (NASDAQ:ADPT) - Seeking Alpha

Click here to get full coverage on Adaptive Biotechnologies (ADPT) Showcases clonoSEQ Test Advances at Key Conferences | ADPT Stock News - GuruFocus

Adaptive Biotechnologies (ADPT) Showcases clonoSEQ Test Advances at Key Conferences | ADPT Stock News  GuruFocus

Adaptive Biotechnologies (ADPT) Showcases clonoSEQ Test Advances at Key Conferences | ADPT Stock News - GuruFocus

Click here to get full coverage on Adaptive Biotechnologies (ADPT) Soars 34% on Strong Q1 Earnings - RagingBull

Adaptive Biotechnologies (ADPT) Soars 34% on Strong Q1 Earnings  RagingBull

Adaptive Biotechnologies (ADPT) Soars 34% on Strong Q1 Earnings - RagingBull

Click here to get full coverage on Adaptive Biotechnologies Holds Annual Shareholders Meeting - TipRanks

Adaptive Biotechnologies Holds Annual Shareholders Meeting  TipRanks

Adaptive Biotechnologies Holds Annual Shareholders Meeting - TipRanks

Click here to get full coverage on Long Term Trading Analysis for (ADPT) - news.stocktradersdaily.com

Long Term Trading Analysis for (ADPT)  news.stocktradersdaily.com

Long Term Trading Analysis for (ADPT) - news.stocktradersdaily.com

Click here to get full coverage on (ADPT) Technical Pivots with Risk Controls - news.stocktradersdaily.com

(ADPT) Technical Pivots with Risk Controls  news.stocktradersdaily.com

(ADPT) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Click here to get full coverage on Adaptive Biotechnologies Reports First Quarter 2025 Financial Results - GlobeNewswire

Adaptive Biotechnologies Reports First Quarter 2025 Financial Results  GlobeNewswire

Adaptive Biotechnologies Reports First Quarter 2025 Financial Results - GlobeNewswire

Click here to get full coverage on Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025 - GlobeNewswire

Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025  GlobeNewswire

Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025 - GlobeNewswire

Click here to get full coverage on Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting - GlobeNewswire

Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting  GlobeNewswire

Adaptive Biotechnologies Announces Over 65 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 66th ASH Annual Meeting - GlobeNewswire

Click here to get full coverage on Adaptive Biotechnologies Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Adaptive Biotechnologies Full Year 2024 Earnings: EPS Beats Expectations  Yahoo Finance

Adaptive Biotechnologies Full Year 2024 Earnings: EPS Beats Expectations - Yahoo Finance

Click here to get full coverage on Cathie Wood's Ark Invest Continues To Offload Tesla As Elon Musk Moves On From Trump Administration - Benzinga

Cathie Wood's Ark Invest Continues To Offload Tesla As Elon Musk Moves On From Trump Administration  Benzinga

Cathie Wood's Ark Invest Continues To Offload Tesla As Elon Musk Moves On From Trump Administration - Benzinga

Click here to get full coverage on Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions - GlobeNewswire

Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions  GlobeNewswire

Adaptive Biotechnologies Announces New Data at the 66th ASH Annual Meeting Highlighting Advances in MRD Testing with clonoSEQ® and Its Impact on Blood Cancer Treatment Decisions - GlobeNewswire

Click here to get full coverage on Adaptive Biotechnologies: Q1 Earnings Snapshot - San Antonio Express-News

Adaptive Biotechnologies: Q1 Earnings Snapshot  San Antonio Express-News

Adaptive Biotechnologies: Q1 Earnings Snapshot - San Antonio Express-News

Click here to get full coverage on Earnings call transcript: Adaptive Biotechnologies beats Q1 2025 EPS forecast - Investing.com

Earnings call transcript: Adaptive Biotechnologies beats Q1 2025 EPS forecast  Investing.com

Earnings call transcript: Adaptive Biotechnologies beats Q1 2025 EPS forecast - Investing.com

Click here to get full coverage on Adaptive Biotechnologies stock soars on Q1 earnings beat By Investing.com - Investing.com Nigeria

Adaptive Biotechnologies stock soars on Q1 earnings beat By Investing.com  Investing.com Nigeria

Adaptive Biotechnologies stock soars on Q1 earnings beat By Investing.com - Investing.com Nigeria

Click here to get full coverage on Adaptive Biotechnologies Corp reports results for the quarter ended March 31 - Earnings Summary - TradingView

Adaptive Biotechnologies Corp reports results for the quarter ended March 31 - Earnings Summary  TradingView

Adaptive Biotechnologies Corp reports results for the quarter ended March 31 - Earnings Summary - TradingView

Click here to get full coverage on Adaptive Biotechnologies Lifts Forecasts And Sees Share Price Jump - Finimize

Adaptive Biotechnologies Lifts Forecasts And Sees Share Price Jump  Finimize

Adaptive Biotechnologies Lifts Forecasts And Sees Share Price Jump - Finimize

Click here to get full coverage on Transcript : Adaptive Biotechnologies Corporation Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 08 - marketscreener.com

Transcript : Adaptive Biotechnologies Corporation Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 08  marketscreener.com

Transcript : Adaptive Biotechnologies Corporation Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 08 - marketscreener.com

Click here to get full coverage on CAVA Athleisure Launches ADPT An Innovative Fabric Blend For All-day Ease - IFAB MEDIA

CAVA Athleisure Launches ADPT An Innovative Fabric Blend For All-day Ease  IFAB MEDIA

CAVA Athleisure Launches ADPT An Innovative Fabric Blend For All-day Ease - IFAB MEDIA

Click here to get full coverage on Adaptive Biotechnologies Reports First Quarter 2025 Financial Results - TradingView

Adaptive Biotechnologies Reports First Quarter 2025 Financial Results  TradingView

Adaptive Biotechnologies Reports First Quarter 2025 Financial Results - TradingView

Click here to get full coverage on Nasdaq Surges Over 300 Points; Apple Shares Fall After Q2 Results - Benzinga

Nasdaq Surges Over 300 Points; Apple Shares Fall After Q2 Results  Benzinga

Nasdaq Surges Over 300 Points; Apple Shares Fall After Q2 Results - Benzinga

Click here to get full coverage on Allogene's Q1 Earnings In Line With Estimates, Sales Nil - The Globe and Mail

Allogene's Q1 Earnings In Line With Estimates, Sales Nil  The Globe and Mail

Allogene's Q1 Earnings In Line With Estimates, Sales Nil - The Globe and Mail

Click here to get full coverage on Cathie Wood Buys More NVIDIA And AMD Stock As Chinese Tech Giants Stockpile Chips Amid Looming US Export Curbs - Advanced Micro Devices (NASDAQ:AMD), Adaptive Biotechnologies (NASDAQ:ADPT) - Benzinga

Cathie Wood Buys More NVIDIA And AMD Stock As Chinese Tech Giants Stockpile Chips Amid Looming US Export Curbs - Advanced Micro Devices (NASDAQ:AMD), Adaptive Biotechnologies (NASDAQ:ADPT)  Benzinga

Cathie Wood Buys More NVIDIA And AMD Stock As Chinese Tech Giants Stockpile Chips Amid Looming US Export Curbs - Advanced Micro Devices (NASDAQ:AMD), Adaptive Biotechnologies (NASDAQ:ADPT) - Benzinga

Click here to get full coverage on Adaptive Biotechnologies Soars 120% In 9 Months - Can The Momentum Continue? - RTTNews

Adaptive Biotechnologies Soars 120% In 9 Months - Can The Momentum Continue?  RTTNews

Adaptive Biotechnologies Soars 120% In 9 Months - Can The Momentum Continue? - RTTNews

Click here to get full coverage on Cathie Wood's Ark Invest Loads Up On Beam Therapeutics, Nu Holdings: Offloads MercadoLibre, Adaptive Biotechnologies - Benzinga

Cathie Wood's Ark Invest Loads Up On Beam Therapeutics, Nu Holdings: Offloads MercadoLibre, Adaptive Biotechnologies  Benzinga

Cathie Wood's Ark Invest Loads Up On Beam Therapeutics, Nu Holdings: Offloads MercadoLibre, Adaptive Biotechnologies - Benzinga

Click here to get full coverage on Vanguard Group Inc's Strategic Acquisition in Adaptive Biotechnologies Corp - GuruFocus

Vanguard Group Inc's Strategic Acquisition in Adaptive Biotechnologies Corp  GuruFocus

Vanguard Group Inc's Strategic Acquisition in Adaptive Biotechnologies Corp - GuruFocus

Click here to get full coverage on Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Benzinga

Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket  Benzinga

Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket - Benzinga

Click here to get full coverage on Trupanion Posts Better-Than-Expected Results, Joins Duolingo, DexCom, Exact Sciences And Other Big Stocks Moving Higher On Friday - Benzinga

Trupanion Posts Better-Than-Expected Results, Joins Duolingo, DexCom, Exact Sciences And Other Big Stocks Moving Higher On Friday  Benzinga

Trupanion Posts Better-Than-Expected Results, Joins Duolingo, DexCom, Exact Sciences And Other Big Stocks Moving Higher On Friday - Benzinga

Click here to get full coverage on Guess, Tesla, Nvidia And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga

Guess, Tesla, Nvidia And Other Big Stocks Moving Lower In Friday's Pre-Market Session  Benzinga

Guess, Tesla, Nvidia And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga

Click here to get full coverage on Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics Which Laid Off Over A Quarter Of Its Workforce - Benzinga

Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics Which Laid Off Over A Quarter Of Its Workforce  Benzinga

Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics Which Laid Off Over A Quarter Of Its Workforce - Benzinga

Click here to get full coverage on Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In 2025 - Benzinga

Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In 2025  Benzinga

Adaptive Biotechnologies Corp (ADPT)

Price Chart

Key Statistics

Technicals

About ADPT

Latest News

Adaptive Biotechnologies (ADPT) Initiates Coverage with Buy Rating | ADPT Stock News - GuruFocus

Assessing Adaptive Biotechnologies: Insights From 5 Financial Analysts - Benzinga

What Makes Adaptive Biotechnologies (ADPT) a New Buy Stock - Nasdaq

Advanced Charts

Top Gainers

Top Losers